Shattuck Labs (STTK) EBITDA Margin (2019 - 2025)
Shattuck Labs (STTK) reported EBITDA Margin of 1005.4% for Q3 2025, down 45091.0% year-over-year from N/an in Q3 2024, and down 81.32% quarter-over-quarter from 554.49% in Q3 2024.
Shattuck Labs (STTK) EBITDA Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of EBITDA Margin data on file, last reported at 1005.4% in Q3 2025.
- EBITDA Margin for Q3 2025 came in at 1005.4%, down 45091.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4987.4% (down 345475.0% YoY), and the FY2025 annual result was 4880.5%, down 356234.0% from the prior year.
- EBITDA Margin declined to 1005.4% in Q3 2025 per STTK's latest filing, from 554.49% in the prior quarter.
- Over five years, EBITDA Margin peaked at 30.42% in Q4 2021 and troughed at 55904.0% in Q2 2022.
- A 5-year average of 8869.88% and a median of 1661.17% in 2024 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin slumped 5532357 bps in 2022, then surged 4536350 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 30.42% in 2021, then slumped by 21131 bps to 6398.46% in 2022, then surged by 61 bps to 2477.59% in 2023, then surged by 78 bps to 554.49% in 2024, then slumped by 81 bps to 1005.4% in 2025.
- Business Quant data shows STTK's EBITDA Margin at 1005.4% in Q3 2025, 554.49% in Q3 2024, and 1338.91% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,005.40% |
| Sep 30, 2024 | -554.49% |
| Jun 30, 2024 | -1,338.91% |
| Mar 31, 2024 | -1,661.17% |
| Dec 31, 2023 | -2,477.59% |
| Sep 30, 2023 | -4,002.92% |
| Jun 30, 2023 | -10,540.50% |
| Mar 31, 2023 | -35,414.04% |
| Dec 31, 2022 | -6,398.46% |
| Sep 30, 2022 | -11,726.89% |
| Jun 30, 2022 | -55,904.00% |
| Dec 31, 2021 | 30.42% |
| Sep 30, 2021 | -927.21% |
| Jun 30, 2021 | -580.43% |
| Mar 31, 2021 | -546.70% |
| Dec 31, 2020 | -899.03% |
| Sep 30, 2020 | -486.94% |
| Jun 30, 2020 | -198.21% |
| Mar 31, 2020 | -218.18% |
| Dec 31, 2019 | -263.52% |